Westmount Partners, LLC Clearside Biomedical, Inc. Transaction History
Westmount Partners, LLC
- $329 Billion
- Q4 2024
A detailed history of Westmount Partners, LLC transactions in Clearside Biomedical, Inc. stock. As of the latest transaction made, Westmount Partners, LLC holds 21,500 shares of CLSD stock, worth $20,425. This represents 0.01% of its overall portfolio holdings.
Number of Shares
21,500Holding current value
$20,425% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding CLSD
# of Institutions
55Shares Held
12MCall Options Held
54.7KPut Options Held
50.7K-
Vanguard Group Inc Valley Forge, PA2.84MShares$2.7 Million0.0% of portfolio
-
Act Capital Management, LLC Wayne, PA2.2MShares$2.09 Million3.43% of portfolio
-
Carmignac Gestion Paris, I01.93MShares$1.84 Million0.04% of portfolio
-
Black Rock Inc. New York, NY798KShares$758,2300.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny745KShares$707,6440.0% of portfolio
About Clearside Biomedical, Inc.
- Ticker CLSD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,190,700
- Market Cap $57.2M
- Description
- Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...